Skip to main content
Olema Pharmaceuticals, Inc. logo

Olema Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · OLMA ISIN · US68062P1066 US Manufacturing
Open in API
Filings indexed 506 across all filing types
Latest filing 2020-10-30 Capital/Financing Update
Country US United States of America
Listing US OLMA

About Olema Pharmaceuticals, Inc.

https://olema.com/

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women's cancers. The company concentrates on endocrine-driven diseases, with a primary emphasis on breast cancer. Its lead product candidate, palazestrant (OP-1250), is an oral complete estrogen receptor (ER) antagonist (CERAN) and selective ER degrader (SERD). Palazestrant is under investigation in clinical trials as a potential treatment for patients with ER-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Olema is advancing a pipeline of drug candidates with the goal of developing improved therapeutic options for cancer patients.

Recent filings

Filing Released Lang Actions
S-1
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, as indicated by the header and the text referencing the Securities Act of 1933. It includes detailed information about the company, Olema Pharmaceuticals, Inc., its business overview, risk factors, management discussion and analysis, financial data, and other disclosures typical of a registration statement for an initial public offering or other securities offering. This type of filing is related to capital raising activities and is not an annual report, earnings release, or other types of filings listed. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is the actual registration statement, not just an announcement of a report, so it is not RPA or RNS.
2020-10-30 English
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a letter from a law firm responding to comments from the SEC staff regarding a Confidential Draft Registration Statement on Form S-1 for Olema Pharmaceuticals, Inc. It references the submission of Amendment No. 1 to the Draft Registration Statement and addresses specific SEC comments on disclosures, clinical trials, use of proceeds, and other regulatory compliance matters. The document is not the registration statement itself but a response letter related to the registration process. It is a regulatory communication with the SEC concerning a securities offering registration, not a financial report, earnings release, or other types of filings. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory communications that do not fit other specific categories.
2020-10-23 English
Capital/Financing Update 2020
Capital/Financing Update Classification · 100% confidence The document is a confidential draft registration statement filed with the SEC on Form S-1 by Olema Pharmaceuticals, Inc. It is a registration statement under the Securities Act of 1933, which is used for initial public offerings or other securities offerings. The text includes detailed information about the company, its business, management, financial data, and the securities being registered. This type of filing is related to capital raising activities and financing. It is not an annual report, earnings release, or any other type of report but a registration statement for securities offering. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains substantive content, not just an announcement or certification, so it is not RPA or RNS.
2020-10-23 English
Regulatory Filings 2020
Regulatory Filings
2020-10-16 English
Regulatory Filings 2020
Regulatory Filings
2020-10-13 English
Regulatory Filings 2020
Regulatory Filings
2020-10-13 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.